KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) EBIAT (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed EBIAT for 17 consecutive years, with $5.1 billion as the latest value for Q4 2025.

  • Quarterly EBIAT rose 49.11% to $5.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $26.8 billion through Dec 2025, up 90.56% year-over-year, with the annual reading at $26.8 billion for FY2025, 90.56% up from the prior year.
  • EBIAT hit $5.1 billion in Q4 2025 for Johnson & Johnson, down from $5.2 billion in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $11.0 billion in Q1 2025 to a low of -$68.0 million in Q2 2023.
  • Historically, EBIAT has averaged $4.5 billion across 5 years, with a median of $4.4 billion in 2022.
  • Biggest five-year swings in EBIAT: plummeted 101.49% in 2023 and later surged 4886.76% in 2024.
  • Year by year, EBIAT stood at $3.7 billion in 2021, then increased by 17.53% to $4.3 billion in 2022, then decreased by 6.06% to $4.0 billion in 2023, then decreased by 15.26% to $3.4 billion in 2024, then soared by 49.11% to $5.1 billion in 2025.
  • Business Quant data shows EBIAT for JNJ at $5.1 billion in Q4 2025, $5.2 billion in Q3 2025, and $5.5 billion in Q2 2025.